Press Releases

A new analysis led by physicians at Roswell Park Comprehensive Cancer Center, published in JAMA Network Open, shows that some patients with small node-negative breast tumors that test positive for both the hormone receptor (HR) and ERBB2, also known as HER2/neu, proteins could benefit from chemotherapy in addition to surgery, radiation and endocrine therapy.

While it has long been thought that locally-delivered radiation therapy typically does not help to shrink tumors outside the field of irradiation, new preclinical research from a team at Roswell Park Comprehensive Cancer Center suggests a strategy for significantly increasing both the local and distant, or “abscopal,” effects of radiation.

Roswell Park Comprehensive Cancer Center plans to offer convalescent plasma — in this case, plasma from the donated blood of healthy individuals who have had COVID-19 but have now fully recovered and cleared the virus from their bodies — to patients with severe or life-threatening COVID-19 through an expanded access program authorized by the U.S. FDA.

Our patients and their loved ones have many questions about cancer care during the COVID-19 pandemic. Every Friday, our experts will host webinars to help provide answers on a variety of topics.

Roswell Park IV, PhD, an ardent supporter of the Buffalo, New York, cancer center that was founded by and named for his great-grandfather, died Wednesday, April 8, after a 20-year battle with the disease. He was 66.

In the latest update from Roswell Park - hand sanitizer made on campus, positivity signage inspires in Kaminski Park, April Ride for Roswell donations to support COVID-19 Response Fund.

As the world continues to grapple with the COVID-19 pandemic, the Center for Indigenous Cancer Research (CICR) at Roswell Park Comprehensive Cancer Center is hosting a virtual conversation as it relates to cancer care and coronavirus within Indigenous communities.

Roswell Park Comprehensive Cancer Center and the University at Buffalo have launched a collaborative clinical trial that will make a new investigational treatment option available to local patients who are hospitalized and diagnosed with critical or severe COVID-19.